International Tax Review is part of Legal Benchmarking Limited, 1-2 Paris Garden, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Search results for

There are 33,160 results that match your search.33,160 results
  • The Hong Kong government will try to introduce its first ever sales tax in the March budget.
  • Information technology associations in India are hoping that the Ministry of Finance agrees to their demands for tax breaks in the forthcoming budget.
  • Daniel Horowitz, Stephen Bates, Monica Zubler, Ronald Dabrowski, Richard Hoge and Patrick Jackman are all joining Lainoff at KPMG. Lainoff himself is taking up the position of partner in charge of international corporate tax at the firm's Washington office. Of the other six, one will be stationed in New York, while five will remain in the capital.
  • The Mexican firm, which is owned by Grupo Financiero Bancomer and the US health insurer Aetna, is the country's third-largest insurance company with $300 million of annual premiums.
  • The media group has announced a further agreement with the UK music company EMI, in a deal worth $20 billion.
  • The deal, to be completed at the end of the first quarter, will create CNET Networks, which will have 10 million users and 2,600 advertisers and merchants.
  • The acquisition will include Medical Manager's subsidiary, Carelnsite, a supplier of clinical communication services.
  • Harmonisation of tax laws – Council Directive 90/435/EEC – Parent companies and subsidiaries – Derogation from the prohibition of withholding tax, in the member state of the subsidiary, on profits distributed by the subsidiary to the parent company.
  • Global Crossing is seeking a $1.2 billion loan to to acquire Racal's assets.
  • The £114 billion ($XX) agreement will create the world's largest pharmaceuticals group, with combined annual sales of more than £15 billion. The new company, Glaxo SmithKline, will control 7.3% of the world's drugs market. Glaxo shareholders will receive 58.75% of the new company's share capital, with SmithKline taking 41.25%.